Publication|Articles|July 29, 2025
- Product Profile: ZYNYZ (retifanlimab-dlwr injection, for intravenous use)
Product Profile: ZYNYZ (retifanlimab-dlwr injection, for intravenous use)
Advertisement
Learn about a treatment for squamous cell carcinoma of the anal canal.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Rural health is ailing. Is $50 billion enough to heal it?
2
Recombinant shingles vaccine linked to lower cardiovascular disease risk
3
Real-World Safety Experience and Clinical Takeaways from the BE BOLD Trial
4
Medicare Part D redesign reshapes market
5









